Jupiter Asset Management Ltd. Acquires 180,937 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jupiter Asset Management Ltd. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1,673.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 191,751 shares of the medical instruments supplier’s stock after acquiring an additional 180,937 shares during the period. Jupiter Asset Management Ltd. owned about 0.09% of DENTSPLY SIRONA worth $12,234,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XRAY. First Trust Advisors LP increased its position in shares of DENTSPLY SIRONA by 203.9% during the 1st quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock worth $4,517,000 after purchasing an additional 61,111 shares during the last quarter. Amundi Pioneer Asset Management Inc. increased its position in shares of DENTSPLY SIRONA by 39.9% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock worth $9,157,000 after purchasing an additional 52,645 shares during the last quarter. Comerica Bank increased its holdings in shares of DENTSPLY SIRONA by 28.8% during the 4th quarter. Comerica Bank now owns 59,576 shares of the medical instruments supplier’s stock worth $3,410,000 after acquiring an additional 13,317 shares during the last quarter. California Public Employees Retirement System increased its holdings in shares of DENTSPLY SIRONA by 5.7% during the 4th quarter. California Public Employees Retirement System now owns 536,321 shares of the medical instruments supplier’s stock worth $28,082,000 after acquiring an additional 29,025 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 154.8% during the 4th quarter. Daiwa Securities Group Inc. now owns 26,510 shares of the medical instruments supplier’s stock worth $1,388,000 after acquiring an additional 16,107 shares during the last quarter. Hedge funds and other institutional investors own 94.50% of the company’s stock.

In related news, insider Walter Petersohn sold 17,425 shares of DENTSPLY SIRONA stock in a transaction on Tuesday, May 25th. The stock was sold at an average price of $67.40, for a total transaction of $1,174,445.00. Following the sale, the insider now directly owns 55,222 shares in the company, valued at $3,721,962.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Eric Brandt sold 7,600 shares of DENTSPLY SIRONA stock in a transaction on Wednesday, March 17th. The stock was sold at an average price of $63.21, for a total value of $480,396.00. Following the sale, the director now owns 38,131 shares in the company, valued at $2,410,260.51. The disclosure for this sale can be found here. Company insiders own 0.69% of the company’s stock.

A number of research analysts have commented on the company. Barclays upped their price objective on DENTSPLY SIRONA from $50.00 to $55.00 and gave the company an “underweight” rating in a report on Tuesday, March 2nd. HC Wainwright upped their price objective on DENTSPLY SIRONA from $60.00 to $72.00 and gave the company a “neutral” rating in a report on Friday, May 7th. Robert W. Baird upped their price objective on DENTSPLY SIRONA from $71.00 to $78.00 and gave the company an “outperform” rating in a report on Friday, May 7th. Barrington Research upped their target price on DENTSPLY SIRONA from $71.00 to $77.00 and gave the company an “outperform” rating in a research report on Friday, May 7th. Finally, Piper Sandler upped their price objective on DENTSPLY SIRONA from $70.00 to $75.00 and gave the stock an “overweight” rating in a research report on Thursday, May 6th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $62.11.

NASDAQ XRAY opened at $66.07 on Friday. The business’s 50 day simple moving average is $66.31. DENTSPLY SIRONA Inc. has a one year low of $40.15 and a one year high of $69.54. The firm has a market capitalization of $14.42 billion, a PE ratio of 83.63, a P/E/G ratio of 1.10 and a beta of 0.93. The company has a quick ratio of 0.99, a current ratio of 1.40 and a debt-to-equity ratio of 0.39.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 6th. The medical instruments supplier reported $0.72 EPS for the quarter, topping the consensus estimate of $0.55 by $0.17. DENTSPLY SIRONA had a return on equity of 9.45% and a net margin of 4.99%. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $944.89 million. During the same quarter last year, the firm posted $0.43 earnings per share. The firm’s revenue was up 17.5% on a year-over-year basis. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 2.86 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 9th. Investors of record on Friday, June 25th will be paid a dividend of $0.11 per share. The ex-dividend date is Thursday, June 24th. This represents a $0.44 annualized dividend and a yield of 0.67%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.10. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 22.35%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: Understanding debt-to-equity ratio in fundamental analysis

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.